已入深夜,您辛苦了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!祝你早点完成任务,早点休息,好梦!

Real-world analysis of cost, treatment patterns, and outcomes of patients with metastatic cutaneous squamous cell carcinoma in the US

医学 西妥昔单抗 内科学 卡铂 放射治疗 肿瘤科 化疗 顺铂 回顾性队列研究 癌症 结直肠癌
作者
Xue Song,Chieh-I Chen,Gerasimos Konidaris,Nicole M. Zimmerman,Emily Ruiz
出处
期刊:Expert Review of Pharmacoeconomics & Outcomes Research [Taylor & Francis]
卷期号:: 1-10
标识
DOI:10.1080/14737167.2023.2223982
摘要

Objectives To describe real-world characteristics and treatment patterns of patients with metastatic cutaneous squamous cell carcinoma (mCSCC).Methods This retrospective observational study used MarketScan Commercial and Medicare Supplemental claims databases (1/1/2013–7/31/2019). Adult patients with mCSCC who initiated non-immunotherapy systemic treatment (i.e. index event) between 1 January 2014 and 31 December 2018 were assessed for treatment patterns, all-cause and CSCC-related healthcare resource utilization, costs, and mortality .Results Overall, 207 patients were included in the study(mean age 64.8 years, 76.3% male), 59.4% had prior radiotherapy, and 58.9% had prior CSCC-related surgery. During follow-up, 75.8%, 51.7%, and 35.7% of patients received chemotherapy, radiotherapy, and targeted therapy as first-line treatment, respectively. Cisplatin (32.9%) and carboplatin (22.7%) were the most common chemotherapy agents, and cetuximab (32.4%) was the most common targeted therapy during the first-line.Probability of death (95% CI) at month 6, year 1, and year 2 was 24% (16–32%), 50% (40 − 59%), and 67% (56 − 75%), respectively. Average CSCC-related healthcare costs were $5,354 per person per month (PPPM), with outpatient costs being the major cost driver at 96.4% ($5,160 PPPM).Conclusion During 2014–2018, patients with mCSCC were commonly treated with cisplatin and cetuximab; prognosis was generally poor. These results indicate opportunity for new treatments to improve survival outcomes.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
zzzkyt发布了新的文献求助10
刚刚
Hyh_orz应助onlyan采纳,获得20
1秒前
2秒前
3秒前
霜鸣完成签到,获得积分20
3秒前
霜鸣发布了新的文献求助10
9秒前
10秒前
lynn完成签到,获得积分10
12秒前
xiaoleihu完成签到 ,获得积分10
12秒前
singber完成签到,获得积分10
12秒前
龙猫爱看书完成签到,获得积分10
13秒前
ceeray23发布了新的文献求助20
16秒前
梦醒了完成签到 ,获得积分10
17秒前
111111完成签到,获得积分10
21秒前
赘婿应助科研通管家采纳,获得10
24秒前
xdlongchem完成签到,获得积分10
25秒前
eee完成签到 ,获得积分10
31秒前
cherlie完成签到,获得积分10
41秒前
44秒前
46秒前
2213sss完成签到,获得积分10
47秒前
aa完成签到,获得积分10
47秒前
GL发布了新的文献求助10
49秒前
111完成签到 ,获得积分10
52秒前
咋取名字发布了新的文献求助10
52秒前
Hiraeth完成签到 ,获得积分10
56秒前
yls完成签到,获得积分10
57秒前
火山完成签到 ,获得积分10
58秒前
icel完成签到,获得积分10
58秒前
59秒前
Shiku完成签到,获得积分10
1分钟前
彭于晏应助CNS采纳,获得10
1分钟前
Heaven发布了新的文献求助10
1分钟前
cmq完成签到 ,获得积分10
1分钟前
生姜批发刘哥完成签到 ,获得积分10
1分钟前
苏打发布了新的文献求助10
1分钟前
哈哈哈哈完成签到,获得积分10
1分钟前
1分钟前
nicenice完成签到,获得积分10
1分钟前
nicenice发布了新的文献求助10
1分钟前
高分求助中
The Mother of All Tableaux: Order, Equivalence, and Geometry in the Large-scale Structure of Optimality Theory 3000
A new approach to the extrapolation of accelerated life test data 1000
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
基于可调谐半导体激光吸收光谱技术泄漏气体检测系统的研究 350
Robot-supported joining of reinforcement textiles with one-sided sewing heads 320
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3990012
求助须知:如何正确求助?哪些是违规求助? 3532047
关于积分的说明 11256141
捐赠科研通 3270918
什么是DOI,文献DOI怎么找? 1805105
邀请新用户注册赠送积分活动 882270
科研通“疑难数据库(出版商)”最低求助积分说明 809216